04.06.2026
New COO assumes responsibility for Production, Quality and Supply at medac
04.06.2026
Wedel, 4 June 2026 – With the appointment of Dr Christian Matschke as Chief Operating Officer (COO), the medac Group adds further expertise to the management of its manufacturing, quality and supply processes. His areas of responsibility include Manufacturing, Quality, Supply Chain, Occupational Health & Safety, and cross-site operational processes.
The focus of his role is to ensure the safe, timely and high-quality supply of medicines and medical devices to patients and partners worldwide. At the same time, efficiency, productivity and the international competitiveness of medac’s manufacturing and supply structures will continue to be strengthened.
"A stable supply, efficient processes and high quality standards are essential to reliably provide patients worldwide with our therapies. Christian Matschke brings extensive experience in international manufacturing and supply organisations," says Frank Lucaßen, CEO of the medac Group.
Focus on efficiency, automation and collaboration
A key aspect of the COO role is the continuous improvement of processes and the further optimisation of the manufacturing network. This includes the increased use of new technologies, the automation of processes and close collaboration across all areas of the company.
For Dr Matschke, the interaction between people, processes and technology is particularly important. Clear responsibilities, transparency and cross-functional collaboration form the foundation of a modern leadership culture.
Experience in manufacturing and transformation
Dr Christian Matschke has many years of international experience leading pharmaceutical manufacturing, quality and supply organisations in regulated environments. His previous areas of focus include the development of global manufacturing networks, ensuring reliable supply, and building efficient cross-site structures and management teams. In addition, he brings extensive expertise in operational transformation and cross-functional collaboration.
With this appointment, medac continues to strengthen its manufacturing and supply capabilities and reinforces its commitment to the reliable provision of essential therapies worldwide.